search for books and compare prices
Tables of Contents for Allogenic Immunotherapy for Malignant Disease
Chapter/Section Title
Page #
Page Count
Series Introduction
v
 
Preface
vii
 
Contributors
xiii
 
Introduction: The Graft-Versus-Leukemia Effect
1
12
Paul M. Sondel
Part I: Biological Basis of the GVL Effect
The Immune Response to Alloantigens
13
26
Graham M. Lord
Robert I. Lechler
Experimental Animal Models in the Study of GVL Reactions
39
36
Robert L. Truitt
Robert Korngold
Bryon D. Johnson
Robert Townsend
Bruce R. Blazar
Effector Cells and Mechanisms of the GVL Effect
75
44
Yin-Zheng Jiang
Minor Histocompatibility Antigens in GVL
119
16
Tuna Mutis
Els Goulmy
Tissue-Specific Antigens in GVL
135
20
Jeffrey J. Molldrem
Oncoproteins as Tumor-Specific Antigens
155
18
Carlo Gambacorti-Passerini
Part II: The GVL Effect in Clinical Practice
GVL Effects in Human Marrow Stem-Cell Transplants
173
26
John Barrett
The GVL Effect in Donor Lymphocyte Transfusion
199
24
Frits van Rhee
Hans-Jochem Kolb
The Graft-Versus-Myeloma Effect
223
16
Jayesh Mehta
The Graft-Versus-Tumor Effect
239
16
Richard W. Childs
John Barrett
Adoptive Allogeneic Cell-Mediated Immunotherapy and Nonmyeloablative Stem-Cell Transplantation
255
12
Shimon Slavin
Shoshana Morecki
Elizabeth Naparstek
Arnon Nagler
Gabor Varadi
Rami Ben-Yosef
Reuven Or
Clinical and Basic Science Studies of Human Umbilical Cord Blood: Implications for the GVL Effect Following Cord Blood Transplantation
267
18
Jay Gaddy
Pierluigi Porcu
Hal E. Broxmeyer
Part III: Modulation and Application of GVL Effects
Separating GVHD and GVL Reactions
285
22
Dimitrios Mavroudis
John Barrett
T-Cell Subsets and Separation of GVL from GVHD
307
8
Sergio A. Giralt
Richard E. Champlin
Molecular Immunological Modulation of Target Cells to Enhance the GVL Effect
315
26
Joachim L. Schultze
John G. Gribben
Genetic Modulation of Effector Cells to Enhance GVL Effects
341
18
Helen E. Heslop
Koichi Moriwaki
Leukemia-Reactive T Cells in Adoptive Immunotherapy for Relapsed Leukemia After Allogeneic Transplantation
359
10
J. H. Frederick Falkenburg
Roelof Willemze
The BCR-ABL Oncoprotein and Immunological Targeting: Vaccination for Tumor Prevention and Therapy
369
10
George J. A. ten Bosch
Onno C. Leeksma
Cornelius J. M. Melief
Index
379